Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$931,073
+$23,586 QoQ
Shares Held
5,941
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#644
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $135,758,423 across 9 Drug Manufacturers - General names. NVS ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,680 | $57,188,826 | |
| 2 | ABBV |
AbbVie Inc.
|
111,026 | $27,938,581 | |
| 3 | JNJ |
Johnson & Johnson
|
82,604 | $20,978,936 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,260 | $8,000,410 | |
| 5 | AMGN |
Amgen Inc
|
18,021 | $6,525,764 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
47,312 | $5,977,398 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
84,745 | $4,883,006 | |
| 8 | PFE |
Pfizer Inc
|
138,473 | $3,334,429 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $931,073 | 5,941 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $907,487 | 5,941 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $822,532 | 5,966 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $738,149 | 5,756 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $698,953 | 5,776 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $349,824 | 3,138 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $307,304 | 3,158 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $397,739 | 3,458 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $363,986 | 3,419 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $367,477 | 3,799 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $394,186 | 3,904 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $421,191 | 4,135 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $432,601 | 4,287 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $400,936 | 4,358 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $396,264 | 4,368 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $332,999 | 4,381 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $374,975 | 4,436 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $391,891 | 4,466 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $449,770 | 5,142 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $415,114 | 5,076 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $448,627 | 4,917 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $420,305 | 4,917 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $464,784 | 4,922 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $460,801 | 5,299 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $410,322 | 4,698 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $361,790 | 4,388 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||